Synthesis of novel azanorbornylpurine derivatives

Tetrahedron

Volumn 68, Issue 4, 2012, Pages 1286-1298

  Hřebabecký, Hubert ^a   Dejmek, Milan ^a   Dračínský, Martin ^a   Šála, Michal ^a   Leyssen, Pieter ^b   Neyts, Johan ^b   Kaniaková, Martina ^c   Kršek, Jan ^c   Nencka, Radim ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Azanorbornane; Coxsackievirus; Hepatitis C virus; Mitsunobu reaction; Neuronal nicotinic acetylcholine receptor; Purines

Indexed keywords

9 ( 2 AZABICYCLO[2.2.1]HEPT 5 YL) 6 CHLORO 9H PURINE TRIFLUOROACETIC ACID SALT; 9 ( 2 AZABICYCLO[2.2.1]HEPT 5 YL) 9H PURIN 6 AMINE BIS TRIFLUOROACETIC ACID SALT; 9 ( 2 AZABICYCLO[2.2.1]HEPT 5 YL)N CYCLOPROPYL 9H PURIN 6 AMINE BIS TRIFLUOROACETIC ACID SALT; 9 ( 2 AZABICYCLO[2.2.1]HEPT 6 YL) 6 CHLORO 9H PURINE TRIFLUOROACETIC ACID SALT; 9 ( 2 AZABICYCLO[2.2.1]HEPT 6 YL) 9H PURIN 6 AMINE BIS TRIFLUOROACETIC ACID SALT; 9 ( 2 AZABICYCLO[2.2.1]HEPT 6 YL)N CYCLOPROPYL 9H PURIN 6 AMINE BIS TRIFLUOROACETIC ACID SALT; 9 ( 7 AZABICYCLO[2.2.1]HEPT 2 YL)N CYCLOPROPYL 9H PURIN 6 AMINE BIS TRIFLOROACETIC ACID SALT; 9 ( 7 AZABICYCLO[2.2.1]HEPT 2 YL)N CYCLOPROPYL 9H PURIN 6 AMINE BIS TRIFLUOROACETIC ACID SALT; ANTIVIRUS AGENT; AZANORBORNYLPURINE DERIVATIVE; NICOTINIC AGENT; PURINE DERIVATIVE; TERT BUTYL 1 OXO 3 (2 OXOETHYL) 1,3 DIHYDRO 2H ISOINDOLE 2 CARBOXYLATE; TERT BUTYL 2 (6 AMINO 9H PURIN 9 YL) 7 AZABICYCLO[2.2.1]HEPTANE 7 CARBOXYLATE; TERT BUTYL 2 (6 CHLORO 9H PURIN 9 YL) 7 AZABICYCLO[2.2.1]HEPTANE 7 CARBOXYLATE; TERT BUTYL 2 [(5 AMINO 6 CHLOROPYRIMIDIN 4 YL)AMINO] 7 AZABICYCLO[2.2.1]HEPTANE 7 CARBOXYLATE; TERT BUTYL 2 [6 (CYCLOPROPYLAMINO) 9H PURIN 9 YL] 7 AZABICYCLO[2.2.1]HEPTANE 7 CARBOXYLATE; TERT BUTYL 2 AMINO 7 AZABICYCLO[2.2.1]HEPTANE 7 CARBOXYLATE; TERT BUTYL 2 AZIDO 7 AZABICYCLO[2.2.1]HEPTANE 7 CARBOXYLATE; TERT BUTYL 5 (6 AMINO 9H PURIN 9 YL) 2 AZABICYCLO[2.2.1]HEPTANE 2 CARBOXYLATE; TERT BUTYL 5 (6 CHLORO 9H PURIN 9 YL) 2 AZABICYCLO[2.2.1]HEPTANE 2 CARBOXYLATE; TERT BUTYL 5 [(6 CYCLOPROPYLAMINO) 9H PURIN 9 YL] 2 AZABICYCLO[2.2.1]HEPTANE 2 CARBOXYLATE; TERT BUTYL 5 HYDROXY 2 AZABICYCLO[2.2.1]HEPTANE 2 CARBOXYLATE; TERT BUTYL 5 OXO 2 AZABICYCLO[2.2.1]HEPTANE 2 CARBOXYLATE; TERT BUTYL 6 (6 AMINO 9H PURIN 9 YL) 2 AZABICYCLO[2.2.1]HEPTANE 2 CARBOXYLATE; TERT BUTYL 6 (6 CHLORO 9H PURIN 9 YL) 2 AZABICYCLO[2.2.1]HEPTANE 2 CARBOXYLATE; TERT BUTYL 6 [6 (CYCLOPROPYLAMINO) 9H PURIN 9 YL] 2 AZABICYCLO[2.2.1]HEPTANE 2 CARBOXYLATE; TERT BUTYL 6 HYDROXY 2 AZABICYCLO[2.2.1]HEPTANE 2 CARBOXYLATE; TERT BUTYL 6 OXO 2 AZABICYCLO[2.2.1]HEPTANE 2 CARBOXYLATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; COXSACKIE VIRUS; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HEPATITIS C VIRUS; HYDROBORATION; MITSUNOBU REACTION; NONHUMAN; PRIORITY JOURNAL; VERO CELL;

COXSACKIEVIRUS; HEPATITIS C VIRUS;

EID: 84855435010     PISSN: 00404020     EISSN: 14645416     Source Type: Journal    
DOI: 10.1016/j.tet.2011.11.035     Document Type: Article

References (40)

1. G. Stanway, F. Brown, P. Christian, T. Hovi, T. Hyypiä, A.M.Q. King, N.J. Knowles, S.M. Lemon, P.D. Minor, M.A. Pallansch, A.C. Palmenberg, and T. Skern Family Picornaviridae C.M. Fauquet, M.A. Mayo, J. Maniloff, U. Desselberger, L.A. Ball, Virus Taxonomy, Eighth Report of the International Committee on Taxonomy of Viruses 2005 Elsevier/Academic London 757 778
2. N.E. Bowles, P.J. Richardson, E.G. Olsen, and L.C. Archard Lancet 1 1986 1120 1123
3. A.H. Wong, C.S. Lau, P.K.C. Cheng, A.Y.Y. Ng, and W.W.L. Lim J. Med. Virol. 83 2011 483 489
4. H. Jaïdane, P. Sauter, F. Sane, A. Goffard, J. Gharbi, and D. Hober Rev. Med. Virol. 20 2010 265 280
5. M.J. Abzug Pediatr. Infect. Dis. J. 20 2001 758 763
6. H. Kawashima, S. Ryou, S. Nishimata, H. Ioi, Y. Kashiwagi, M. Iizumi, T. Takami, M. Sasamoto, K. Takekuma, A. Hoshika, and T. Mori Pediatr. Int. 46 2004 130 134
7. A.M. De Palma, I. Vliegen, E. De Clercq, and J. Neyts Med. Res. Rev. 28 2008 823 884
8. M. Šála, A.M. De Palma, H. Hřebabecký, R. Nencka, M. Dračínský, P. Leyssen, J. Neyts, and A. Holý Bioorg. Med. Chem. 18 2010 4374 4384
9. M. Šála, H. Hřebabecký, M. Dračínský, M. Masojídková, A.M. De Palma, J. Neyts, and A. Holý Tetrahedron 65 2009 9291 9299
10. H. Hřebabecký, M. Dračínský, A.M. De Palma, J. Neyts, and A. Holý Collect. Czech. Chem. Commun. 74 2009 487 502
11. H. Hřebabecký, M. Dračínský, and A. Holý Collect. Czech. Chem. Commun. 72 2007 1331 1349
12. H. Hřebabecký, M. Dračínský, A.M. De Palma, J. Neyts, and A. Holý Collect. Czech. Chem. Commun. 74 2009 469 485
13. M. Šála, A.M. De Palma, H. Hřebabecký, M. Dejmek, M. Dračínský, P. Leyssen, J. Neyts, H. Mertlíková-Kaiserová, and R. Nencka Bioorg. Med. Chem. Lett. 21 2011 4271 4275
14. J. Daly, T. Tokuyama, T. Fujiwara, R. Highet, and I. Karle J. Am. Chem. Soc. 102 1980 830 836
15. T.F. Spande, H.M. Garraffo, M.W. Edwards, H.J.C. Yeh, L. Pannell, and J.W. Daly J. Am. Chem. Soc. 114 1992 3475 3478
16. B. Badio, and J. Daly Mol. Pharmacol. 45 1994 563 569
17. C. Qian, T. Li, and T.Y. Shen Eur. J. Pharmacol. 250 1993 R13 R14
18. T. Li, J. Eckman, D.F. Huang, and T.Y. Shen Bioorg. Med. Chem. Lett. 3 1993 2759 2764
19. M. Dukat, M.I. Damaj, W. Glassco, D. Dumas, E.L. May, B.R. Martin, and R.A. Glennon Med. Chem. Res. 4 1994 131 139
20. B. Badio, H.M. Garraffo, T.F. Spande, and J.W. Daly Med. Chem. Res. 4 1994 440 448
21. A. Kasyan, C. Wagner, and M.E. Maier Tetrahedron 54 1998 8047 8054
22. K.K.C. Swamy, B.N.N. Kumar, E. Balaraman, and P.K.V.P. Kumar Chem. Rev. 109 2009 2551 2651
23. S.R. Fletcher, R. Baker, M.S. Chambers, R.H. Herbert, S.C. Hobbs, S.R. Thomas, H.M. Verrier, A.P. Watt, and R.G. Ball J. Org. Chem. 59 1994 1771 1778
24. Z.-L. Wei, P.A. Petukhov, Y. Xiao, W. Tückmantel, C. George, K.J. Kellar, and A.P. Kozikowski J. Med. Chem. 46 2003 921 924
25. G.L. Grunewald, T.J. Reitz, A. Hallett, C.D. Rutledge, S. Vollmer, J.M. Archuleta III, and J.A. Ruth J. Med. Chem. 23 1980 614 620
26. F.I. Carroll, F. Liang, H.A. Navarro, L.E. Brieaddy, P. Abraham, M.I. Damaj, and B.R. Martin J. Med. Chem. 44 2001 2229 2237
27. P. Kapferer, and A. Wasella Helv. Chim. Acta 87 2004 2764 2789
28. E. Gómez-Sánchez, E. Soriano, and J. Marco-Contelles J. Org. Chem. 72 2007 8656 8670
29. R.D. Elliott, G.A. Rener, J.M. Riordan, J.A. Secrist III, L.L. Bennett Jr., W.B. Parker, and J.A. Montgomery J. Med. Chem. 37 1994 739 744
30. G.V.B. Madhavan, D.P.C. McGee, R.M. Rydzewski, R. Boehme, J.C. Martin, and E.J. Prisbe J. Med. Chem. 31 1988 1798 1804
31. X. Yin, and S.W. Schneller Tetrahedron Lett. 46 2005 7535 7538
32. W. Wang, H. Jin, N. Fuselli, and T.S. Mansour Bioorg. Med. Chem. Lett. 7 1997 2567 2572
33. J.A. Montgomery, and C. Temple Jr. J. Am. Chem. Soc. 79 1957 5238 5242
34. Y.-H. Cho, V. Zunic, H. Senboku, M. Olsen, and M. Lautens J. Am. Chem. Soc. 128 2006 6837 6846
35. S.L. Huang, K. Omura, and D.J. Swern J. Org. Chem. 41 1976 3329 3331
36. D.M. Hodgson, M.W.P. Bebbington, and P. Willis Org. Biomol. Chem. 1 2003 3787 3798
37. J.M. Vrolijk, A. Kaul, B.E. Hansen, V. Lohmann, B.L. Haagmans, S.W. Schalm, and R. Bartenschlager J. Virol. Methods 110 2003 201 209
38. L. Ke, C.M. Eisenhour, M. Bencherif, and R.J. Lukas J. Pharmacol. Exp. Ther. 286 1998 825 840
39. M.L. Mayer, L. Vyklicky Jr., and J. Clements Nature 338 1989 425 427
40. L. Vyklický Jr., M. Benveniste, and M.L. Mayer J. Physiol. 428 1990 313 331